Genentech Inc. (GNE)
Barbara Hoffman of Piper Jaffray said a negative article last week in Barron's, stating that GNE's Activase tPA may face competition from angioplasty, is old news. The story, which cites a study reported in a March 1993 New England Journal of Medicine article, speculates that Roche's willingness to complete the buyout of GNE may be affected by the potential competition